Cancer Tubulin Inhibitors Market By Product ( Docetaxel, Trastuzumab Emtansine, Abraxane, Brentuximab Vedotin, Cabazitaxel ), By Application ( Non-Small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Colorectal Cancer, Ovarian Cancer ), Industry Trends, Estimation & Forecast, 2017 - 2025
- RnM3857299
|
- 23 December, 2019
|
- 112 Pages
|
- Esticast Research & Consulting
|
- Healthcare